About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 860 record(s)
Req # A-2020-001138
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03052728, E2B_03013912, E2B_03054810, E2B_03051959, E2B_03052089, E2B_03022330, E2B_03050488, E2B_03053990, E2B_03052551, E2B_03033137, E2B_03026742, E2B_03002100, E2B_03002687, E2B_03002829, E2B_03003027, E2B_03132793, E2B_01317652.Organization: Health Canada
March 2021
Req # A-2020-001141
Adverse Reaction Reports (AERs) for ZOPICLONE. Report numbers: 000913270, E2B_02992214, E2B_02993428, E2B_03045681.Organization: Health Canada
March 2021
Req # A-2020-001186
Adverse Reaction Reports (AERs). Report numbers: E2B_02437355, E2B_02437590, E2B_02437670, E2B_02437828, E2B_02438547, E2B_02438757, E2B_02439206, E2B_02439446, E2B_02439883, E2B_02439993, E2B_02440125, E2B_02440393, E2B_02440490, E2B_02441297, E2B_02442301, E2B_02442468, E2B_02442788, E2B_02443563, E2B_02443803, E2B_02444326.Organization: Health Canada
March 2021
Req # A-2020-001197
Adverse Reaction Reports (AERs). Report numbers: E2B_02466069, E2B_02466713, E2B_02467628, E2B_ 02467629, E2B_02467641, E2B_02467645, E2B_02467646, E2B_02467647, E2B_02467657, E2B_02467674, E2B_02468010, E2B_02468016, E2B_02468216, E2B_02468217, E2B_02468222, E2B_02468241, E2B_02468729, E2B_02468855, E2B_02469474, E2B 02470134.Organization: Health Canada
March 2021
Req # A-2020-001200
Adverse Reaction Reports (AERs). Report numbers: E2B_02470184, E2B_02470309, E2B_02470343, E2B_02470345, E2B_02470378, E2B_02470417, E2B_02470426, E2B_02471174, E2B_02471365, E2B_02471461, E2B_02471624, E2B_02471631, E2B_02472611, E2B_02472619, E2B_02472628, E2B_02472633, E2B_02472988, E2B_02475457, E2B_02475462, E2B_02475494.Organization: Health Canada
March 2021
Req # A-2020-001204
Adverse Reaction Reports (AERs). Report numbers: E2B_02475513, E2B_02476661, E2B_02476695, E2B_02476782, E2B_02476812, E2B_02476819, E2B_02476941, E2B_02476986, E2B_02476990, E2B_02476991, E2B_02477278, E2B_02477279, E2B_02477361, E2B_02477377, E2B_02477385, E2B_02477471, E2B_02477675, E2B_02478256, E2B_02478761, E2B_02478811.Organization: Health Canada
March 2021
Req # A-2020-001231
Adverse Drug Reaction (ADR) for Prevegyne. Report number: 000605895.Organization: Health Canada
March 2021
Req # A-2020-001241
Adverse Reaction Reports (AERs). Report numbers: E2B_02558244, E2B_02558625, E2B_02559373, E2B_02559463, E2B_02559469, E2B_02559471, E2B_02559478, E2B_02559487, E2B_02559506, E2B_02559665, E2B_02559674, E2B_02559828, E2B_02560253, E2B_02560278, E2B_02560301, E2B_02560340, E2B_02560443, E2B_02560454, E2B_02560462, E2B_02560599.Organization: Health Canada
March 2021
Req # A-2020-001242
Adverse Reaction Reports (AERs). Report numbers: E2B_02548428, E2B_02548473, E2B_02548529, E2B_02548640, E2B_02548642, E2B_02548763, E2B_02549557, E2B_02549727, E2B_02549746, E2B_02549747, E2B_02549759, E2B_02549860, E2B_02550606, E2B_02551325, E2B_02551353, E2B_02551755, E2B_02552070, E2B_02552356, E2B_02552357, E2B_02553212.Organization: Health Canada
March 2021
Req # A-2020-001260
Adverse Reaction Reports (AERs). Report numbers: E2B_02580672, E2B_02580921, E2B_02581306, E2B_02581330, E2B_02581333, E2B_02581334, E2B_02581335, E2B_02581343, E2B_02581977, E2B_02582233, E2B_02582328, E2B_02582332, E2B_02582474, E2B_02582477, E2B_02582478, E2B_02582479, E2B_02582480, E2B_02582496, E2B_02582497, E2B_02582654.Organization: Health Canada
March 2021